Marinelli O, Romagnoli E, Maggi F, Nabissi M, et al. Exploring treatment with Ribociclib alone or in sequence/combination with
Everolimus in ER(+)HER2(-)Rb wild-type and knock-down in breast cancer cell
lines. BMC Cancer 2020;20:1119.
PMID: 33213401